Actiprotect respirator mask protects against airborne influenza virus

Published: 23-Jul-2009

GSK has developed the Actiprotect disposable respirator mask, which is said to protect the wearer from inhaling airborne influenza virus. It includes an antiviral coating and has been shown to inactivate all influenza strains, including previous strains of H1N1 and H5N1 and an influenza B strain. It has not yet been tested against the pandemic (H1N1) 2009 strain.


Actiprotect has been approved for use in Europe and certain international markets and last month the FDA approved it for occupational use in the US. The US National Institute of Occupational Safety and Health has certified the mask as an N95 respirator (filters at least 95% of airborne particles). GSK says it currently has limited manufacturing capacity for the mask. The company has therefore made investments to increase this capacity and is also seeking additional production capacity with other companies.

GSK already has agreements with several countries to supply the masks. www.gsk.com

You may also like